The Effects of Lithium, Valproic Acid, and Carbamazepine During Pregnancy and Lactation

REFERENCES

• Douglas B. H., Hume A. S. Placental Transfer of Imipramine a Basic, Lipid-Soluble Drug. Am. J. Obstet. Gynecol. 1967; 99: 573–575
   PubMed Web of Science ®Google Scholar
• Giacoia G. P., Catz C. S. Drugs and Pollutants in Breast Milk. Clin. Perinatol. 1979; 6: 181
   PubMed Web of Science ®Google Scholar
• Hammond J. E., Toseland P. A. Placental Transfer of Chlorpromazine. Arch. Dis. Child. 1970; 45: 139
   PubMed Web of Science ®Google Scholar
• Rennert O. M. Drug-Induced Somatic Alterations. Clin. Obstet. Gynecol. 1975; 18(4)185
   PubMedGoogle Scholar
• Mackay A. V., Loose R., Glen A. Labor on Lithium. Br. Med. J. 1976; 1: 878
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Jamision K. R. Manic-Depressive Illness. Oxford UniversityPress, New York 1990
   Google Scholar
• Bowden C. L. Key Treatment Studies of Lithium in Manic-Depressive Illness:Efficacy and Side Effects. J. Clin. Psychiatry 1998; 59(6)13–19
   PubMedGoogle Scholar
• Keck P. E., Jr., McElroy S. L. Outcome in the Pharmacologic Treatment of Bipolar Disorder. J. Clin. Psychopharmacol. 1996; 16(Suppl 1)15S–23S
   PubMedGoogle Scholar
• Anonymous. Teratogenesis with Carbamazepine. Lancet 1991; 337: 1316–1317
   PubMed Web of Science ®Google Scholar
• Post R. M., Rubinow D. R., Uhde T. W., Ballenger J. C., Lake C. R., Linnoila M., Jimerson D. C., Reus V. Effects of Carbamazepine on Nonadrenergic Mechanisms in AffectivelyIll Patients. Psychopharmacology 1985; 87(1)59–63
   PubMedGoogle Scholar
• Zacara G., Messori A. A., Moroni F. Clinical Pharmacokinetics of Valproic Acid. Clin. Pharmacokinet. 1998; 15: 367–389
   Google Scholar
• Nora J. J., Nora A. H., Toews W. H. Lithium Ebstein's Anomaly and Other Congenital Heart Defects. Lancet 1974; 2(7880)594–595
   PubMed Web of Science ®Google Scholar
• Elia J., Katz I. R., Simpson G. M. Teratogenicity of Psychotherapeutic Medications. Psychopharmacol. Bull. 1978; 23(4)531–586
   Google Scholar
• Thiels C. Pharmacotherapy of Psychiatric Disprder in Pregnancy and DuringBreast Feeding. A Review. Pharmacopsychiatry 1987; 20: 133–146
   PubMed Web of Science ®Google Scholar
• Warkany J. Teratogen Update: Lithium. Teratology 1988; 38: 593–596
   PubMedGoogle Scholar
• Kallen B. Comments on Teratogen Update: Lithium. Teratology 1988; 38: 597
   Google Scholar
• Schou M., Goldfield M. D., Weinstein M. R., Villeneuve A. Lithium and Pregnancy: Report from the Register of Lithium Babies. Br. Med. J. 1973; 2(859)135–136
   PubMedGoogle Scholar
• Kerns L. L. Treatment of Mental Disorder in Pregnancy: A Review of PsychotropicDrug Risks and Benefits. J. Nerv. Ment. Dis. 1986; 174: 652–659
   PubMed Web of Science ®Google Scholar
• Leonard A., Hantson P. H., Gerber G. B. Mutagenicity Carcinogenicity and Teratogenicity of Lithium Compounds. Mutat. Res. 1995; 339: 131–137
   PubMed Web of Science ®Google Scholar
• Rane A., Tomson G., Bjarke B. Effects of Maternal Lithium Therapy in a Newborn Infant. J. Pediatr. 1978; 93: 296–297
   PubMed Web of Science ®Google Scholar
• Weinstein M. R., Goldfield M. D. Cardiovascular Malformations with Lithium Use During Pregnancy. Am. J. Psychiatry 1975; 132: 529–531
   PubMed Web of Science ®Google Scholar
• Arnon R. G., Marin-Garcia J., Peeden J. N. Tricuspid Valve Regurgitation and Lithium Carbonate Toxicityin a Newborn Infant. Am. J. Dis. Child. 1981; 135: 941–943
   PubMedGoogle Scholar
• Strothers J. K., Wilson D. W., Royston N. Lithium Toxicity in a Newborn. Br. Med. J. 1973; 3: 233–234
   Web of Science ®Google Scholar
• Kallen B., Tandberg A. Lithium and Pregnancy: A Cohort Study on Manic-Depressive Women. Acta Pediatr. Scand. 1983; 68: 134–139
   Google Scholar
• Amdisen A. Evidence of an Altered Thyroid Function in Man During Treatmentwith Lithium Carbonate. Acta Pediatr. Scand. (Suppl 1) 1969; 207: 59–67
   Google Scholar
• Karlsson K., Lindstedt G., Lundberg P. A., Selstam U. Transplacental Lithium Poisoning: Reversible Inhibition of FetalThyroid. Lancet 1975; 1(7919)1295
   PubMed Web of Science ®Google Scholar
• Krause S., Ebbesen F., Lange A. P. Polyhydramnios with Maternal Lithium Treatment. Obstet. Gynecol. 1990; 75: 504–506
   PubMed Web of Science ®Google Scholar
• Weinstein M. Lithium Treatment of Women During Pregnancy in th e Post Delivery Period. Handbook of Lithium Therapy, F. N. Johnson. UniversityPark Press, Baltimore 1980; 421–429
   Google Scholar
• Yoder M. C., Belik J., Lanvion R. A., Pereira G. R. Infants of Mothers Treated with Lithium During Pregnancy Havean Increased Incidence of Prematurity, Macrosomia, and Perinatal Mortality. Pediatr. Res. 1984; 18: 163A
   Google Scholar
• Jacobson S. J., Jones K., Johnson K., Ceolin L., Kaur P., Sahn D., Donnenfeld A. E., Reider M., Santelli R., Smythe J., Pastuszak A., Einarson T., Koren G. Prospective Multicenter Study of Pregnancy Outcome After LithiumExposure During First Trimester. Lancet 1992; 339(8792)530–533
   PubMed Web of Science ®Google Scholar
• Nishiwaki T., Tanaka K., Sekiya E. Acute Lithium Intoxication in Pregnancy. Int. Gynecol. Obstet. 1996; 52(2)191–192
   PubMed Web of Science ®Google Scholar
• Rosa F. Medicaid Antidepressant Pregnancy Exposure Outcome. Reprod. Toxicol. 1994; 8: 444–445
   Google Scholar
• Goldfield M. D., Weinstein M. R. Lithium Carbonate in Obstetrics: Guidelines for Clinical Use. Am. J. Obstet. Gynecol. 1973; 116: 15–22
   PubMed Web of Science ®Google Scholar
• Vacaflor L., Lehman H. E., Ban T. A. Side Effects and Teratogenicity of Lithium Carbonate Treatment. J. Clin. Pharmacol. 1970; 10(6)387–389
   Web of Science ®Google Scholar
• Krause S., Ebbesen F., Lange A. P. Polyhydramnios with Maternal Lithium Treatment. Obstet. Gynecol. 1990; 75: 504–506
   PubMed Web of Science ®Google Scholar
• Eikmeier G. Fetal Malformations Under Lithium Treatment. Eur. Psychiatry 1996; 11: 376–377
   PubMed Web of Science ®Google Scholar
• Schou M., Amdisen A. Lithium and Pregnancy.Lithium Ingestion by Children Breast-Fedby Women on Lithium Treatment. Br. Med. J. 1973; 2(859)138
   PubMedGoogle Scholar
• Tunnessen W. W., Jr., Hertz C. G. Toxic Effects of Lithium in Newborn Infants: A Commentary. J. Pediatr. 1972; 81: 804–807
   PubMed Web of Science ®Google Scholar
• Sykes P. A., Quarrie J., Alexander F. W. Lithium Carbonate and Breast Feeding. Br. Med. J. 1976; 2: 1299
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Drugs. The Transferof Drugs and Other Chemicals into Human Milk. Pediatrics 1994; 93: 137–150
   PubMed Web of Science ®Google Scholar
• Dickinson R. G., Harland R. C., Lynn R. K., Smith W. B., Gerber N. Transmission of Valproic Acid (Depakene) Across the Placenta:Half-Life of the Drug in Mother and Baby. J. Pediatr. 1979; 94(5)832–835
   PubMed Web of Science ®Google Scholar
• Nau H., Rating S., Koch S., Hauser I., Helge H. Valproic Acid and Its Metabolites: Placental Transfer NeonatalPharmacokinetics Transfer via Mother's Milk and Clinical Status in Neonatesof Epileptic Mothers. J. Pharmacol. Exp. Ther. 1981; 219(3)768–777
   PubMedGoogle Scholar
• Nau H., Helge H., Luck W. Valproic Acid in the Perinatal Period; Decreased Maternal SerumProtein Binding Results in Fetal Accumulation and Neonatal Displacement ofthe Drug and Some Metabolites. J. Pediatr. 1984; 104: 627–634
   PubMed Web of Science ®Google Scholar
• Froescher W., Gugler R., Niesen M., Hoffmann F. Protein Binding in Valproic Acid in Maternal and Umbilical CordSerum. Epilepsia 1984; 25(2)244–249
   PubMed Web of Science ®Google Scholar
• Janz D. The Teratogenic Risk of Antiepileptic Drugs. Epilepsia 1975; 16: 159–169
   PubMed Web of Science ®Google Scholar
• Kelly T. E. Teratogenicity of Antiepileptic Drugs. I. Review of Literature. Am. J. Med. Genet. 1984; 19: 413–434
   PubMed Web of Science ®Google Scholar
• Anonymous. Valproate: A New Cause of Birth Defects–Reportfrom Italy and Follow-Up from France. CDC Morb. Mortal. Wkly. Rep. 1983; 32: 438–439
   PubMedGoogle Scholar
• Mastroiacovo P., Bertollini R., Morandini S., Segni G. Maternal Epilepsy Valproate Exposure and Birth Defects. Lancet 1983; 2(8365–8366)1499
   PubMed Web of Science ®Google Scholar
• Kallen A. J. Maternal Carbamazepine and Infant Spina Bifida. Reprod. Toxicol. 1994; 8(3)203–205
   PubMed Web of Science ®Google Scholar
• Guibaud S., Robert E., Simplot A., Boisson C., Francannet C., Patouraux M. H. Prenatal Diagnosis of Spina Bifida Aperta After First-TrimesterValproate Exposure. Prenat. Diag. 1993; 13(8)772–773
   PubMed Web of Science ®Google Scholar
• Lammer E. J., Sever L. E., Oakley G. P., Jr. Teratogen Update: Valproic Acid. Teratology 1987; 35: 465–473
   PubMedGoogle Scholar
• Kallen B., Robert E., Mastroiacovo P., Martinez-Frias M. L., Castilla E. E., Cocchi G. Anticonvulsant Drugs and Malformations: Is There a Drug Specificity?Eur. J. Epidemiol. 1989; 5(1)31–36
   Web of Science ®Google Scholar
• Battino D., Binelli S., Caccamo M. L., Canevini M. P., Canger R., Como M. L., Croci D., De Giambattista M., Granata T., Pardi G., Avanzini G. Malformations in Offspring of 305 Epileptic Women: A ProspectiveStudy. Acta Neurol. Scand. 1992; 85(3)204–207
   PubMed Web of Science ®Google Scholar
• Omtzigt J. G., Los F. J., Grobbee D. E., Pijpers L., Jahoda M. G., Brandenburg H., Stewart P. A., Gaillard H. L., Sachs E. S., Wladimiroff J. W., Lindhout D. The Risk of Spina Bifida Aperta After First-Trimester Exposureto Valposure to Valproate in a Prenatal Cohort. Neurology 1992; 42(Suppl 5)119–125
   PubMedGoogle Scholar
• Bjerkedal T., Czeizel A., Goujard J., Kallen B., Mastroiacova P., Nevin N., Oakley G., Jr., Robert E. Valproic Acid and Spina Bifida. Lancet 1982; 2(8307)1096
   PubMed Web of Science ®Google Scholar
• Lindhout D. Valproate and Spina Bifida in the Netherlands (abstract). Teratology 1985; 32: 15A
   Google Scholar
• Jeavons P. M. Sodium Valproate and Neural Tube Defects. Lancet 1982; 2: 1282–1283
   Google Scholar
• Center for Disease Control (CDC): Valproic Acid and Spina Bifida.A Preliminary Report – France. Morb. Motal. Wkly. Rep. 1982; 31: 565–566
   PubMedGoogle Scholar
• Omtzigt J. G., Nau H., Los F. J., Pijpers L., Lindhout D. The Disposition of Valproate and Its Metabolites in the LateFirst Trimester and Early Second Trimester of Pregnancy in Maternal SerumUrine and Amniotic Fluid: Effect of Dose Co-Medication and the Presence ofSpina Bifida. Eur. J. Clin. Pharmacol. 1992; 43(4)381–388
   PubMed Web of Science ®Google Scholar
• Lindhaut D., Omtzigt J. G., Cornel M. C. Spectrum of Neural Tube Defects in 34 Infants Prenatally Exposedto Antiepileptic Drugs. Neurology 1992; 42(Suppl 5)111–118
   Google Scholar
• Ardinger H. H., Atkins J. F., Blackson D. R., Elsas L. J., Clarren S. K., Livingston S., Flannery D. B., Pellock J. M., Harrod M. J., Lammer E. J., Majewski F., Schinzel A., Toriello H. V., Hanson J. W. Verification of the Fetal Valproate Syndrome Phenotype. Am. J. Med. Genet. 1988; 29(1)171–185
   PubMed Web of Science ®Google Scholar
• Lindhout D., Schmidt D. In Utero Exposure to Valproateand Neural Tube Defects. Lancet 1986; 1(8494)1392–1393
   PubMed Web of Science ®Google Scholar
• Weinbaum P., Cassidy S., Vintzibos A., Campbell W. A., Ciarleglio L., Nochimson D. J. Prenatal Detection of a Neural Tube Defect After Fetal Exposureto Valproic Acid. Obstet. Gynecol. 1986; 67(Suppl 3)S31–S33
   PubMed Web of Science ®Google Scholar
• Iqbal M. M. Prevention of Neural Tube Defects by Periconceptional Use ofFolic Acid. Pediatrics in Review 2000; 21(2)58–66
   PubMedGoogle Scholar
• Sanders R. C., James A. G. The Principles and Practice of Ultrasonographyin Obstetrics and Gynecology. Appleton Century-Crofts, NewYork 1985; 247–248
   Google Scholar
• Samren E. B., Van Duijn C. M., Koch S., Hiilesma V. K., Klepel H., Bardy A. H., Mannagetta G. B., Deichl A. W., Gaily E., Granstrom M. L., Meinardi H., Grobbee D. E., Hofman A., Janz D., Lindhout D. Maternal Use of Antiepileptic Drugs and the Risk of Major CongenitalMalformations: A Joint European Prospective Study of Human Teratogenesis Associatedwith Maternal Epilepsy. Epilepsia 1997; 38(9)981–990
   PubMed Web of Science ®Google Scholar
• Iqbal M. M. Periconceptual Folic Acid to Prevent Neural Tube Defects. N. Carolina Med. J. 2000; 61(4)218–219
   PubMedGoogle Scholar
• Christianson A. L., Chesler N., Kromberg J. G.R. Fetal Valproate Syndrome: Clinical and Neurodevelopmental Featuresin Two Sibling Pairs. Dev. Med. Clin. Neurol. 1994; 36: 361–369
   PubMed Web of Science ®Google Scholar
• Winter R. M., Donnai D., Burn J., Tucker S. M. Fetal Valproate Syndrome: Is There a Recognizable Phenotype?. J. Med. Genet. 1987; 24(11)692–695
   PubMed Web of Science ®Google Scholar
• Jager-Roman E., Deichi A., Jakob S., Hartmann A. M., Koch S., Rating D., Steldinger R., Nau H., Helgi H. Fetal Growth Major Malformations and Minor Anomalies in InfantsBorn to Women Receiving Valproic Acid. J. Pediatr. 1986; 108(6)997–1004
   PubMed Web of Science ®Google Scholar
• Tein I., MacGregor D. L. Possible Valproate Teratogenicity. Arch. Neurol. 1985; 42: 291–293
   PubMed Web of Science ®Google Scholar
• Thisted E., Ebbesen F. Malformations Withdrawal Manifestations and Hypoglycemia AfterExposure to Valproate In Utero. Arch. Dis. Child. 1993; 69: 288–291
   PubMed Web of Science ®Google Scholar
• Langer B., Haddad J., Gasser B., Maubert M., Schlaeder G. Isolated Fetal Bilateral Ray Reduction Associated with ValproicAcid Usage. Fetal Diagn. Ther. 1994; 9(3)155–158
   PubMed Web of Science ®Google Scholar
• Majer R. V., Green P. J. Neonatal Afibrinogenemia Due to Sodium Valproate. Lancet 1987; 2: 740–741
   PubMed Web of Science ®Google Scholar
• Webster W. S., Howe A. M., Lipson A. H. The Role of Vitamin K in Prenatal Development. Teratology 1995; 15(4)285
   Google Scholar
• Vert P., Deblay M. F., Andre M. Follow-up Study on Growth and Neurologic Development of Children Born to Epileptic Mothers. Epilepsy, Pregnancy and the Child, D. Janz, M. Dam, A. Richens. Raven Press, New York 1982; 433–436
   Google Scholar
• Mountain K. R., Hirsch J., Gallus A. S. Neonatal Coagulation Defect Due to Anticonvulsant Drug Treatmentin Pregnancy. Lancet 1970; 256–268
   PubMedGoogle Scholar
• Dalens B., Raynaud E. J., Gaulme J. Teratogenicity of Valproic Acid. J. Pediatr. 1980; 97(2)332–333
   PubMed Web of Science ®Google Scholar
• Leguis E., Jaeken J., Eggermont E. Sodium Valproate Pregnancy and Infantile Fatal Liver Failure. Lancet 1987; 2: 1518–1519
   Web of Science ®Google Scholar
• Bantz E. W. Valproic Acid and Congenital Malformations. A Case Report. Clin. Pediatr. 1984; 23(6)352–353
   PubMed Web of Science ®Google Scholar
• Nakane Y., Okuma T., Takahashi T., Sato Y., Fukushima Y., Kumashiro H., Ono T., Takahashi T., Aoki Y., Kazamatsuri H., Inami M., Komai S., Seino M., Miyakoshi M., Tanimura T., Hazama H., Kawahara R., Otsuki S., Hosokawa K., Inanaga K., Nakazawa Y., Yamamoto K. Multi-Institutional Study on the Teratogenicity and Fetal Toxicityof Antiplatelet Drugs: A Report of a Collaborative Study Group in Japan. Epilepsia 1980; 21(6)663–680
   PubMed Web of Science ®Google Scholar
• Boussemart T., Bonneau D., Levard G., Bertheir M., Oriot D. Omphalocele in a Newborn Baby Exposed to Sodium Valproate InUtero. Eur. J. Pediatr. 1995; 154: 220–201
   PubMed Web of Science ®Google Scholar
• Simila S., Von Wondt L., Hartikainen-Sorri A. L., Kappa P., Saukkonen A. L. Sodium Valproate Pregnancy and Neonatal Hyperglycemia. Arch. Dis. Child. 1979; 54(12)985–986
   PubMed Web of Science ®Google Scholar
• Ebbesen F., Jorgensen A. M., Hoseth E., Kaad P-H., Moller M. Neonatal Hypoglycemia After Exposure In Utero to Valproate. Pediatr. Res. 1998; 44(3)439
   Google Scholar
• Hurd R. W., Wilder B. S., Van Rinsvelot H. A. Birth Defects and Zinc (Letter). Lancet 1980; 8173: 883
   Google Scholar
• Andermann E., Andermann F., Dansky L. V. Counseling for Epileptic Women of Childbearing Age. Advances in Epileptology, XIIth Epilepsy InternationalSymposium, M. Dam, L. Gram, J. K. Penry. Raven Press, New York 1981; 219–227
   Google Scholar
• Kaneko S., Otani K., Fukushima Y., Ogawa Y., Nomura Y., Ono T., Nakane Y., Teranishi T., Goto M. Teratogenicity of Antiepileptic Drugs: Analysis of PossibleRisk Factors. Epilepsia 1988; 29(4)459–467
   PubMed Web of Science ®Google Scholar
• Creizel A. E., Bod M., Halasz P. Evaluation of Anticonvulsant Drugs During Pregnancy in a Population-BasedHungarian Study. Eur. J. Epidemiol. 1992; 8(1)122–127
   PubMed Web of Science ®Google Scholar
• Koch S., Losche G., Jager-Roman E., Jakob S., Rating D., Deichl A., Helge H. Major Birth Malformations and Antiepileptic Drugs. Neurology 1992; 42(Suppl 5)83–88
   PubMedGoogle Scholar
• Von Unruh G. E., Froescher W., Hoffmann F., Niesen M. Valproic Acid in the Breast-Milk: How Much Is Really There?Ther. Drug Monit. 1984; 6(3)272–276
   PubMed Web of Science ®Google Scholar
• Starreveld-Zimmerman A. A.E., Van der Kolk W. J., Meinardi H., Elshove J. Are Anticonvulsant Teratogenic?. Lancet 1973; 2: 48–49
   PubMed Web of Science ®Google Scholar
• Lander C. M., Edwards V. E., Endie M. J., Tyrer J. H. Plasma Anticonvulsant Concentrations During Pregnancy. Neurology 1977; 27: 128–131
   PubMed Web of Science ®Google Scholar
• Thomas D., Buchanan N. Teratogenic Effects of Anticonvulsants. J. Pediatr. 1981; 99: 163
   PubMed Web of Science ®Google Scholar
• Meyer J. G. Teratogenic Risk of Antiplatelet Drugs. Epilepsia 1975; 16: 159–169
   PubMed Web of Science ®Google Scholar
• Niesen M., Froscher W. Finger and Toenail Hypoplasia After Carbamazepine Monotherapyin Late Pregnancy. Neuropediatrics 1985; 16: 167–168
   PubMed Web of Science ®Google Scholar
• Bertollini R., Mastroiacovo P., Segni G. Maternal Epilepsy and Birth Defects: A Case Control Study inthe Italian Multicenter Registry of Birth Defects (IPIMC). Eur. J. Epidemiol. 1985; 1: 67–72
   PubMedGoogle Scholar
• Bod M. Teratogenic Evaluation of Anticonvulsants in a Population BasedHungarian Material. Teratology 1989; 40(3)277
   Google Scholar
• Hughes R. L. Spina Bifida in Infants of Women Taking Carbamazepine. N. Engl. J. Med. 1991; 325: 664
   PubMedGoogle Scholar
• Jones K. L., Lacro R. V., Johnson K. A., Adams J. Pattern of Malformations in the Children of Women Treated withCarbamazepine During Pregnancy. N. Engl. J. Med. 1989; 320: 1661–1666
   PubMed Web of Science ®Google Scholar
• Frey B., Schubiger G., Musy J. P. Transient Cholestatic Hepatitis in a Neonate Associated withCarbamazepine Exposure During Pregnancy and Breast Feeding. Eur. J. Pediatr. 1990; 150(2)136–138
   PubMed Web of Science ®Google Scholar
• Oakeshott P. Prevention of Neural Tube Defects. Lancet 1994; 343: 123–124
   PubMedGoogle Scholar
• Kaneko S., Fukushima Y., Sato T., Ogawa Y., Ono T., Kan R., Nakane Y., Teranishi T., Goto M. Teratogenicity Antiplatelet Drugs: A Prospective Study. Jpn. J. Psych. Neurol. 1986; 40: 447–450
   Google Scholar
• Lindhout D., Hoppener R. J., Meinardi H. Teratogenicity of Antiepileptic Drug Combinations with SpecialEmphasis on Epoxidation (of Carbamazepine). Epilepsia 1984; 25(1)77–83
   PubMed Web of Science ®Google Scholar
• Lindhout D., Meinardi H., Barth P. G. Hazards of Fetal Exposure to Drug Combinations. Epilepsy Pregnancy and the Child, D. Janz, M. Dam, H. Helge, A. Richens, S. Schmidt. Raven Press, New York 1982; 275–281
   Google Scholar
• McMullin G. P. Teratogenic Effects of Anticonvulsants. Br. Med. J. 1971; 4: 430
   PubMed Web of Science ®Google Scholar
• Millar J. H.D., Nevin N. L. Congenital Malformations and Anticonvulsant Drugs. Lancet 1973; 1: 328
   PubMed Web of Science ®Google Scholar
• Little B. B., Santos-Ramos R., Newell J. F., Maberry M. C. Megadose Carbamazepine During the Period of Neural Tube Closure. Obstet. Gynecol. 1993; 8(4 Pt 2 Suppl)705–708
   Google Scholar
• Merlob P., Mor N., Litwin A. Transient Hepatic Dysfunction in an Infant of an Epileptic MotherTreated with Carbamazepine During Pregnancy and Breast-Feeding. Ann. Pharmacother. 1992; 26(12)1563–1565
   PubMed Web of Science ®Google Scholar
• Baptista T., Araujo H., Rada P., Hernandez L. Congenital Neuroblastoma in a Boy Born to a Woman with BipolarDisorder Treated with Carbamazepine During Pregnancy. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998; 22(3)445–454
   PubMed Web of Science ®Google Scholar
• Al-Shammri S., Guberman A., Hsu E. Neuroblastoma and Fetal Exposure to Phenytoin in a Child WithoutDysmorphic Features. Can. J. Neuro. Sci. 1992; 19: 243–245
   PubMed Web of Science ®Google Scholar
• Sutcliffe A. G., Jones R. B., Woodruff G. Eye Malformations Associated with Treatment with CarbamazepineDuring Pregnancy. Ophthalmic Genet. 1998; 19(2)59–62
   PubMed Web of Science ®Google Scholar
• Legido A., Toomey K., Goldsmith L. Congenital Rib Anomalies in a Fetus Exposed to Carbamazepine. Clin. Pediatr. 1991; 30(1)63–64
   PubMed Web of Science ®Google Scholar
• Robertson I. G., Donnai D., D'souza S. Cranial Nerve Agenesis in a Fetus Exposed to Carbamazepine. Dev. Med.Child. Neurol. 1983; 25: 540–541
   PubMed Web of Science ®Google Scholar
• Bell A. D., Gerlis L. M., Variend S. Persistent Right Umbilical Vein – Case Report and Reviewof Literature. Int. J. Cardiol. 1986; 10(2)167–176
   PubMed Web of Science ®Google Scholar
• Hiilesmaa V. K., Teramo K., Granstrom M. L., Brady A. H. Fetal Head Growth Retardation Associated with Maternal AntiepilepticDrugs. Lancet 1981; 2: 165–167
   PubMed Web of Science ®Google Scholar
• Bertollini R., Kallen B., Mastroiacovo P., Robert E. Anticonvulsant Drugs in Monotherapy: Effect on the Fetus. Eur. J. Epidemiol. 1987; 3: 164–171
   PubMed Web of Science ®Google Scholar
• Keller D. M. Teratologic Effects of Carbamazepine. N. Engl. J. Med. 1989; 321(21)1480–1482
   PubMedGoogle Scholar
• Scialli A. R., Lione A. Teratogenic Effects of Carbamazepine. N. Engl. J. Med. 1989; 321(21)1480
   PubMedGoogle Scholar
• Ornoy A., Cohen I. Follow-up Studies of Children Born to Epileptic Women Treatedwith Carbamazepine. Teratology 1995; 51(3)169
   Google Scholar
• Ornoy A., Cohen E. Outcome of Children Born to Epileptic Mothers Treated with CarbamazepineDuring Pregnancy. Arch. Dis. Child. 1996; 75(6)517–520
   PubMed Web of Science ®Google Scholar
• Gaily E., Kantola-Sorsa E., Granstrom M-L. Intelligence of Children of Epileptic Mothers. J. Pediatr. 1988; 113: 677–684
   PubMed Web of Science ®Google Scholar
• Van der Pol M. C., Hadders-Algra M., Huisjes H. J., Touwen B. C.L. Antiepileptic Medication in Pregnancy: Late Effects on Children'sCentral Nervous System Development. Am. J. Obstet. Gynecol. 1991; 164: 121–128
   PubMed Web of Science ®Google Scholar
• Lindhout D., Omtzigt J. G.C. Teratogenic Effects of Antiepileptic Drugs: Implications forthe Management of Epilepsy in Women of Childbearing Age. Epilepsia 1994; 35(Suppl 4)S19–S28
   PubMed Web of Science ®Google Scholar
• Froescher W., Eichelbaum M., Niesen M., Dietrich K., Rausch P. Carbamazepine Levels in Breast Milk. Ther. Drug. Monit. 1984; 6(3)266–271
   PubMed Web of Science ®Google Scholar
• Wong S. H. Monitoring of Drugs in Breast Milk. Ann. Clin. Lab. Sci. 1985; 15(2)100–1105
   PubMed Web of Science ®Google Scholar
• Kok T. H., Taitz L. S., Bennett J. J., Holt D. W. Drowsiness Due to Clemastine Transmitted in Breast Milk. Lancet 1982; 1: 914–915
   PubMed Web of Science ®Google Scholar
• Brent N. B., Wisner K. L. Fluoxetine and Carbamazepine Concentrations in a Nursing Mother/InfantPair. Clin. Pediatr. 1998; 37: 41–44
   PubMed Web of Science ®Google Scholar